SALA ISABELLA MARIA

Ruolo:
Contrattista di ricerca
Settore scientifico disciplinare:
Statistica medica (MEDS-24/A)
Gruppo scientifico disciplinare:
STATISTICA MEDICA, IGIENE GENERALE E APPLICATA E SCIENZE INFERMIERISTICHE GENERALI, CLINICHE, PEDIATRICHE E OSTETRICO-GINECOLOGICHE E NEONATALI (06/MEDS-24)

Pubblicazioni

  • Sala, I (2026). Random forest regression for predicting healthcare costs using administrative databases. (Tesi di dottorato, , 2026). Dettaglio

  • Conforti, F., Nekljudova, V., Sala, I., Ascari, R., Solbach, C., Untch, M., et al. (2025). Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer. JOURNAL OF CLINICAL ONCOLOGY, 43(12), 1441-1452 [10.1200/JCO-24-01360]. Dettaglio

  • Ferri, S., Marzio, V., Cavaglià, E., Valli, N., Bagnardi, V., Oriecuia, C., et al. (2025). Severe Asthma and Sleep Disorders: A Severe Asthma Network Italy (SANI) Registry Analysis. JOURNAL OF ASTHMA AND ALLERGY, 18, 1661-1673 [10.2147/jaa.s558611]. Dettaglio

  • Canonica, G., Blasi, F., Paggiaro, P., Heffler, E., Braido, F., Brussino, L., et al. (2025). Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI). THE WORLD ALLERGY ORGANIZATION JOURNAL, 18(1) [10.1016/j.waojou.2024.101016]. Dettaglio

  • Conforti, F., Bagnardi, V., Sala, I. (2025). Reply to: “Inappropriate Conclusions on Surrogate End Points in Early Breast Cancer Trials” and “Methodologic Considerations in Assessing Invasive Disease-Free Survival as a Surrogate End Point for Overall Survival in Trials for Early Breast Cancer”. JOURNAL OF CLINICAL ONCOLOGY, 43(24), 2754-2756 [10.1200/JCO-25-01041]. Dettaglio